Prescribing of Drugs for Attention-Deficit Hyperactivity Disorder in Opioid Maintenance Treatment Patients in Norway

Publisher： Karger

E-ISSN： 1421-9891|20|2|59-65

ISSN： 1022-6877

Source： European Addiction Research, Vol.20, Iss.2, 2013-09, pp. : 59-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents

By Akhondzadeh Shahin   Mohammadi MR   Momeni F  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 609-614

Future Medicine

Access to resources Recommend Favorite

Influence of Attention Deficit Hyperactivity Disorder and Conduct Disorder on Opioid Dependence Severity and Psychiatric Comorbidity in Chronic Methadone-Maintained Patients

By  

European Addiction Research, Vol. 17, Iss. 1, 2010-09 ,pp. : 10-20

Karger

Access to resources Recommend Favorite

Attention Deficit Hyperactivity Disorder and Obsessive-Compulsive Disorder among Former Heroin Addicts Currently in Methadone Maintenance Treatment

By  

Psychopathology, Vol. 45, Iss. 5, 2012-07 ,pp. : 327-333

Karger

Access to resources Recommend Favorite

Are patients with bipolar disorder and comorbid attention‐deficit hyperactivity disorder more neurocognitively impaired?

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 19, Iss. 8, 2017-12 ,pp. : 637-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1167-1174

John Wiley & Sons Inc

Access to resources Recommend Favorite